{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-008708","form_type":"8-K","ticker":"HROW","cik":"0001360214","company_name":"HARROW, INC.","filed_at":"2023-03-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.612689+00:00","generated_at":"2026-06-17T17:49:14.724928+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Harrow reports FY22 revenue $88.6M (+22% YoY), core net income positive; guides FY23 rev $135-143M, adj EBITDA $44-50M","bullets":["Full-year 2022 revenues $88.6M, up 22% from $72.5M; core net income $1.5M vs loss of $4.4M in 2021.","Q4 2022 core EPS $0.07 diluted, vs loss ($0.12) in Q4 2021; GAAP net income $1.1M.","Reaffirms 2023 guidance: net revenues $135M-$143M, Adjusted EBITDA $44M-$50M.","FDA-approved IHEEZO received permanent J-Code and pass-through reimbursement; launch expected May 2023.","Sold non-ophthalmology assets; acquired U.S. rights to five branded ophthalmic products."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-008708","json":"https://secwatch.observer/filing/0001493152-23-008708.json","markdown":"https://secwatch.observer/filing/0001493152-23-008708.md","text":"https://secwatch.observer/filing/0001493152-23-008708.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1360214/000149315223008708/0001493152-23-008708-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1360214/000149315223008708/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T17:49:14.724928+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f8426550192dc18356be4b427a3b23e8591b2f9","claim":"HARROW, INC. reported the year ended December 31, 2022 results: revenue $88,595,000, net income $(14,086,000), EPS (0.51).","evidence_excerpt":"Fourth quarter and year-end 2022 figures of merit: For the Three Months Ended December 31, For the Years Ended December 31, 2022 2021 2022 2021 Net revenues $ 20,329,000 $ 20,188,000 $ 88,595,000 $ 72,476,000 Gross margin 71 % 75 % 71 % 75 % Core gross margin (1) 71 % 75 % 73 % 75 % Net income (loss) 1,055,000 (7,418,000 ) (14,086,000 ) (18,479,000 ) Core net income (loss) (1) 2,104,000 (3,525,000 ) 1,540,000 (4,353,000 ) Adjusted EBITDA (1)(2) 1,089,000 (1,482,000 ) 13,017,000 11,378,000 Basic and diluted net income (loss) per share 0.04 (0.27 ) (0.51 ) (0.69 )","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360214/000149315223008708/0001493152-23-008708-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2022"},{"label":"Revenue","value":"$88,595,000"},{"label":"Net income","value":"$(14,086,000)"},{"label":"EPS","value":"(0.51)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"8208f4d014d44b05b7a42e464a7d69ecb12ee728","claim":"HARROW, INC. reported the three months ended December 31, 2022 results: revenue $20,329,000, net income $1,055,000, EPS 0.04.","evidence_excerpt":"Fourth quarter and year-end 2022 figures of merit: For the Three Months Ended December 31, For the Years Ended December 31, 2022 2021 2022 2021 Net revenues $ 20,329,000 $ 20,188,000 $ 88,595,000 $ 72,476,000 Gross margin 71 % 75 % 71 % 75 % Core gross margin (1) 71 % 75 % 73 % 75 % Net income (loss) 1,055,000 (7,418,000 ) (14,086,000 ) (18,479,000 ) Core net income (loss) (1) 2,104,000 (3,525,000 ) 1,540,000 (4,353,000 ) Adjusted EBITDA (1)(2) 1,089,000 (1,482,000 ) 13,017,000 11,378,000 Basic and diluted net income (loss) per share 0.04 (0.27 ) (0.51 ) (0.69 )","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360214/000149315223008708/0001493152-23-008708-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended December 31, 2022"},{"label":"Revenue","value":"$20,329,000"},{"label":"Net income","value":"$1,055,000"},{"label":"EPS","value":"0.04"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}